HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ki23057

K-samII/FGF-R2 phosphorylation inhibitor for treatment of scirrhous gastric cancer; structure in first source
Networked: 6 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Miwa, Atsushi: 4 articles (08/2011 - 11/2006)
2. Yashiro, Masakazu: 4 articles (08/2011 - 11/2006)
3. Hirakawa, Kosei: 4 articles (08/2011 - 11/2006)
4. Tendo, Masashige: 2 articles (02/2010 - 11/2006)
5. Nakamura, Kazunori: 2 articles (02/2010 - 11/2006)
6. Matsuoka, Tasuku: 2 articles (02/2010 - 11/2006)
7. Matsuzaki, Taro: 2 articles (02/2010 - 11/2007)
8. Qiu, Hong: 1 article (08/2011)
9. Zhang, Xiaotian: 1 article (08/2011)
10. Kaizaki, Ryoji: 1 article (02/2010)

Related Diseases

1. Stomach Neoplasms (Stomach Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Neoplasms (Cancer)
4. Colonic Neoplasms (Colon Cancer)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Vascular Endothelial Growth Factor Receptor-3 (Flt 4)
3. Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
4. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
5. Protein Kinases (Protein Kinase)
6. Etoposide (VP 16)
7. 4- ((4- Fluoro- 2- methyl- 1H- indol- 5- yl)oxy)- 6- methoxy- 7- (3- (pyrrolidin- 1- yl)propoxy)quinazoline (AZD2171)

Related Therapies and Procedures

1. Oral Administration